Oxford Nanopore Technologies plc (LON:ONT – Get Free Report) has received a consensus rating of “Moderate Buy” from the six ratings firms that are currently covering the stock, MarketBeat Ratings reports. One equities research analyst has rated the stock with a hold recommendation and five have issued a buy recommendation on the company. The average 1-year price objective among analysts that have covered the stock in the last year is GBX 198.60.
Several analysts have commented on the stock. Berenberg Bank lowered their price objective on shares of Oxford Nanopore Technologies from GBX 220 to GBX 200 and set a “buy” rating on the stock in a research report on Wednesday, August 19th. Royal Bank Of Canada reaffirmed an “outperform” rating and set a GBX 225 target price on shares of Oxford Nanopore Technologies in a report on Tuesday, May 26th. Citigroup lowered shares of Oxford Nanopore Technologies to a “buy” rating in a research report on Monday, July 20th. JPMorgan Chase & Co. upped their target price on shares of Oxford Nanopore Technologies from GBX 190 to GBX 220 and gave the stock an “overweight” rating in a report on Thursday. Finally, Deutsche Bank Aktiengesellschaft reiterated a “buy” rating and issued a GBX 195 target price on shares of Oxford Nanopore Technologies in a research note on Thursday, August 20th.
Get Our Latest Research Report on ONT
Oxford Nanopore Technologies Price Performance
Oxford Nanopore Technologies (LON:ONT – Get Free Report) last posted its quarterly earnings results on Wednesday, August 19th. The company reported GBX (4.90) earnings per share (EPS) for the quarter. Oxford Nanopore Technologies had a negative net margin of 54.66% and a negative return on equity of 35.45%.
Oxford Nanopore Technologies Company Profile
Oxford Nanopore Technologies’ goal is to bring the widest benefits to society through enabling the analysis of anything, by anyone, anywhere. The Group has developed a new generation of nanopore-based sensing technology that is currently used for real-time, high-performance, accessible, and scalable analysis of DNA and RNA. The technology is used in more than 125 countries, to understand the biology of humans, plants, animals, bacteria, viruses and environments as well as to understand diseases such as cancer.
Featured Stories
- Five stocks we like better than Oxford Nanopore Technologies
- Williams-Sonoma’s Quarter Gave Bulls More Than Just a Beat-and-Raise
- Alcoa’s Gallium Project Opens a New Door Beyond Aluminum
- Oura’s $16 Billion IPO Could Put a New Price on Wearable Tech
- Can Tesla’s Flying Roadster Distract From Its Real Risks?
Receive News & Ratings for Oxford Nanopore Technologies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Oxford Nanopore Technologies and related companies with MarketBeat.com's FREE daily email newsletter.
